ARCHIVES

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Book For Survivors, Other New Publications

August 23, 1991

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

Capitol Hill: Sen. Harkin Introduces NIH Funding Bill That Boosts Budget to $46.2 Billion by 2021

July 25, 2014